It is broadly estimated that JAKs are likely to dominate around 24% of the market which is not a good news for products like Enbrel manufactured by Amgen. It is likely that the drug is to cascade into fast decline as physicians increasingly prefer JAK as a second drug after Humira of AbbVie.
Positive news that holds hope for the medical fraternity and patients is the urging by UK Prime Minister, Theresa May, for the adoption of artificial intelligence by the NHS and technology companies to diagnose critical diseases such as cancer.
The global ultrasounds systems marker is expected to clock a market value in excess of over USD 12,500 million by the end of 2028, recording a CAGR of 5.7% in the forecast period as per findings of global forecasts stated in the report titled 'Ultrasound Systems Market - Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028'.
Patients and Beijing residents are currently benefitting from the new electronic health cards issued by Beijing through the WeChat app; the program is facilitated by Tencent and Sinosoft Technology which is aimed to improve the healthcare services by 2030 through digital cards.
Rheumatoid arthritis (RA) is an autoimmune disease with complex pathogenesis and an extremely high morbidity rate, which seriously affects the quality of the life of patients and brings economic burden to society. Thus, effective treatments of RA has become a global concern of the pharmaceutical industry.
The amazing discovery under the authorship of Professor Chenfang Dong from the Zhejiang University School of Medicine in Hangzhou, China revealed that the widely used osteoporosis drug named zoledronic acid, inhibits UGT8 activity directly, which led to the prevention of basal-like breast cancer.
A research study led by Professor Marina Botto, from the Department of Medicine in Imperial College London, revealed that a particular component of the immune system called C1q triggers an alarm when the body is attacked by a bacteria or virus and helps in coordinating the defense.
Tagworks Pharmaceuticals, based at Radboud University Medical Center, have developed a novel technique for the targeted delivery of ADCs to treat tumors. By the controlled 'click-to-release' of the chemotherapy drug from its tumor-binding carrier, the treatment would reach the right location.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.